Mutya Harsch - 31 May 2023 Form 4 Insider Report for VYNE Therapeutics Inc. (VYNE)

Role: Chief Legal Officer and GC
Signature: /s/ Mutya Harsch
Issuer symbol: VYNE
Transactions as of: 31 May 2023
Net transactions value: +$12,664
Form type: 4
Filing time: 02 Jun 2023, 16:34:17 UTC
Previous filing: 04 Apr 2023
Next filing: 08 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VYNE	Common Stock	Award	$12,664	+3,664	+16%	$3.46	25,907	31 May 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares were acquired under the Issuer's Employee Share Purchase Plan ("ESPP") for the ESPP purchase period beginning on December 1, 2022 and ending on May 31, 2023 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Issuer's common stock on December 1, 2022.

Content

These shares were acquired under the Issuer's Employee Share Purchase Plan ("ESPP") for the ESPP purchase period beginning on December 1, 2022 and ending on May 31, 2023 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Issuer's common stock on December 1, 2022.